John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
2651
Orion Office REIT
ONL
$166M
| $281K | ﹤0.01% |
70,246
+37,296
| +113% | +$146K |
|
2652
Cannae Holdings
CNNE
$668M
| $280K | ﹤0.01% |
+14,707
| New | +$283K |
|
|
SRG
2653
Seritage Growth Properties
SRG
$119M
| $280K | ﹤0.01% |
60,224
+45,637
| +313% | +$214K |
|
2654
Castle Biosciences
CSTL
$1.02B
| $279K | ﹤0.01% |
9,800
-7,000
| -42% | -$178K |
|
2655
Archer Aviation
ACHR
$4.67B
| $279K | ﹤0.01% |
92,231
-1,066,881
| -92% | -$4.08M |
|
2656
Oak Valley Bancorp
OVLY
$289M
| $278K | ﹤0.01% |
10,473
-442
| -4% | -$11.5K |
|
|
SPNS
2657
DELISTED
Sapiens International
SPNS
| $278K | ﹤0.01% |
7,452
+1,035
| +16% | +$37.7K |
|
|
ZIMV
2658
DELISTED
ZimVie
ZIMV
| $278K | ﹤0.01% |
17,491
-38,343
| -69% | -$688K |
|
2659
Crinetics Pharmaceuticals
CRNX
$8.99B
| $277K | ﹤0.01% |
5,414
-5,386
| -50% | -$278K |
|
2660
Bausch Health
BHC
$2.5B
| $275K | ﹤0.01% |
+33,680
| New | +$222K |
|
2661
Empire State Realty Trust
ESRT
$819M
| $274K | ﹤0.01% |
24,724
-6,376
| -21% | -$66.5K |
|
2662
QuinStreet
QNST
$1.18B
| $274K | ﹤0.01% |
14,316
-4,900
| -25% | -$89.3K |
|
2663
Fidelity Stocks for Inflation ETF
FCPI
$290M
| $273K | ﹤0.01% |
+6,300
| New | +$262K |
|
|
SKYT
2664
DELISTED
SkyWater Technology
SKYT
| $273K | ﹤0.01% |
30,032
-15,996
| -35% | -$133K |
|
|
THR
2665
DELISTED
Thermon Group Holdings
THR
| $272K | ﹤0.01% |
9,129
-4,501
| -33% | -$136K |
|
|
SGMO
2666
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $272K | ﹤0.01% |
314,344
-228,850
| -42% | -$168K |
|
2667
Invesco S&P MidCap Value with Momentum ETF
XMVM
$515M
| $272K | ﹤0.01% |
+4,900
| New | +$264K |
|
2668
Ultralife
ULBI
$113M
| $271K | ﹤0.01% |
29,993
-11,062
| -27% | -$114K |
|
|
IMA
2669
ImageneBio Inc
IMA
$63.8M
| $271K | ﹤0.01% |
13,059
-6,681
| -34% | -$135K |
|
2670
OrthoPediatrics
KIDS
$655M
| $271K | ﹤0.01% |
10,000
+299
| +3% | +$9.06K |
|
2671
Cardlytics
CDLX
$25.2M
| $270K | ﹤0.01% |
8,439
-7,443
| -47% | -$413K |
|
2672
CVRx
CVRX
$83.9M
| $270K | ﹤0.01% |
+30,633
| New | +$279K |
|
2673
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.04B
| $269K | ﹤0.01% |
+40,000
| New | +$221K |
|
|
GRDN
2674
Guardian Pharmacy Services
GRDN
$2.39B
| $269K | ﹤0.01% |
+16,000
| New | +$270K |
|
2675
Adaptive Biotechnologies
ADPT
$4.08B
| $268K | ﹤0.01% |
+52,360
| New | +$228K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.